17 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Terumo Capiox NX19 Oxygenator with Reservoir (east Orientation), Terumo Capiox NX19 Oxygenator with Reservoir (west Orientation), Terumo Capiox NX19 Oxygenator (east Orientation), Terumo Capiox NX19 Oxygenator (west Orientation)

FDA 510(k)
FDA Class 2 ·Cardiovascular

BOSS Instruments

FDA UDI
BOSS INSTRUMENTS, LTD., INC.·00888515023703·Ribbon Retractor, 5/8" width, 6 3/4"

Restore

FDA UDI
KEYSTONE DENTAL, INC.·D768L18095001K0·Cover Screw

STIWELL MED4

FDA 510(k)
FDA Class 2 ·Physical Medicine

VENNER PNEUX P.Y. (TM) TRACHEOSTOMY TUBE

FDA 510(k)
FDA Class 2 ·Anesthesiology

GMK-SPHERE TIBIAL TRAY FIXED CEMENTED SIZE T3-I4 L

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code JWH·October 24, 2019

LOCKING SCREW, FULLY THREADED 5X55 MM

FDA Adverse Event
Injury ·STRYKER OSTEOSYNTHESIS KIEL·Product code HSB·September 30, 2010

AUTO LUBE SYSTEM

FDA Adverse Event
Malfunction ·DEPUY SYNTHES POWER TOOLS·Product code GEI·October 17, 2014

LEAD MODEL 303

FDA Adverse Event
Injury ·CYBERONICS, INC.·Product code LYJ·July 22, 2011

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

FDA Adverse Event
Death ·AV-TEMECULA-CT·Product code NIQ·June 20, 2013

LOW PROFILE SELF-TAPPING BONE SCREW

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code LPH·April 9, 2018

M2A TAPER UNIVERSAL ALTERNATE BEARING SHELL

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWY·October 10, 2017

COLLARLESS BI-METRIC POROUS STEM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code LPH·October 10, 2017

M2A TAPER LINER

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWY·October 10, 2017

BI-METRIC/X POR NC LAT 14X150

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code LPH·September 12, 2017

St. Jude Medical CONFIRM Rx Insertable Cardiac Monitor, Sterile EO, Model #: DM3500 The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 11, 2018

cobas 6000 Modular Series system; Part Numbers: 1. 04745914001 cobas c 501 module; 2. 05036453001 cobas 6000 UL c 501 + Core Fix configuration; 3. 05036453692 - cobas 6000 UL + CORE CU; and 4. 05860636001 cobas 6000 c 501 (UL) V

FDA Enforcement
Class II ·Terminated·Roche Diagnostics Corporation·March 14, 2018